BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23771920)

  • 61. Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype.
    Ester WA; van Duyvenvoorde HA; de Wit CC; Broekman AJ; Ruivenkamp CA; Govaerts LC; Wit JM; Hokken-Koelega AC; Losekoot M
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4717-27. PubMed ID: 19864454
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.
    Papadopoulou A; Issakidis M; Gole E; Kosma K; Fryssira H; Fretzayas A; Nicolaidou P; Kitsiou-Tzeli S
    Eur J Pediatr; 2012 Jan; 171(1):51-8. PubMed ID: 21590266
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
    Binder G
    Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pre- and postnatal growth failure with microcephaly due to two novel heterozygous IGF1R mutations and response to growth hormone treatment.
    Gkourogianni A; Andrade AC; Jonsson BA; Segerlund E; Werner-Sperker A; Horemuzova E; Dahlgren J; Burstedt M; Nilsson O
    Acta Paediatr; 2020 Oct; 109(10):2067-2074. PubMed ID: 32037650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
    El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
    Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Profiles and Genetic Spectra of 814 Chinese Children With Short Stature.
    Li X; Yao R; Chang G; Li Q; Song C; Li N; Ding Y; Li J; Chen Y; Wang Y; Huang X; Shen Y; Zhang H; Wang J; Wang X
    J Clin Endocrinol Metab; 2022 Mar; 107(4):972-985. PubMed ID: 34850017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic causes of proportionate short stature.
    Argente J; Pérez-Jurado LA
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):499-522. PubMed ID: 30086871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation.
    Kawashima Y; Kanzaki S; Yang F; Kinoshita T; Hanaki K; Nagaishi J; Ohtsuka Y; Hisatome I; Ninomoya H; Nanba E; Fukushima T; Takahashi S
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4679-87. PubMed ID: 15928254
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel mutations and their genotype-phenotype correlations in patients with Noonan syndrome, using next-generation sequencing.
    Tafazoli A; Eshraghi P; Pantaleoni F; Vakili R; Moghaddassian M; Ghahraman M; Muto V; Paolacci S; Golyan FF; Abbaszadegan MR
    Adv Med Sci; 2018 Mar; 63(1):87-93. PubMed ID: 28957739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic evaluation of short stature.
    Dauber A; Rosenfeld RG; Hirschhorn JN
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3080-92. PubMed ID: 24915122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations.
    Nilsson O; Guo MH; Dunbar N; Popovic J; Flynn D; Jacobsen C; Lui JC; Hirschhorn JN; Baron J; Dauber A
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1510-8. PubMed ID: 24762113
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genotype-phenotype correlations in Noonan syndrome.
    Zenker M; Buheitel G; Rauch R; Koenig R; Bosse K; Kress W; Tietze HU; Doerr HG; Hofbeck M; Singer H; Reis A; Rauch A
    J Pediatr; 2004 Mar; 144(3):368-74. PubMed ID: 15001945
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
    Brasil AS; Malaquias AC; Wanderley LT; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
    Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):717-22. PubMed ID: 21340158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.
    Malaquias AC; Noronha RM; Souza TTO; Homma TK; Funari MFA; Yamamoto GL; Silva FV; Moraes MB; Honjo RS; Kim CA; Nesi-França S; Carvalho JAR; Quedas EPS; Bertola DR; Jorge AAL
    Horm Res Paediatr; 2019; 91(4):252-261. PubMed ID: 31132774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exome sequencing and subsequent association studies identify five amino acid-altering variants influencing human height.
    Kim JJ; Park YM; Baik KH; Choi HY; Yang GS; Koh I; Hwang JA; Lee J; Lee YS; Rhee H; Kwon TS; Han BG; Heath KE; Inoue H; Yoo HW; Park K; Lee JK
    Hum Genet; 2012 Mar; 131(3):471-8. PubMed ID: 21959382
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations.
    Atik T; Aykut A; Hazan F; Onay H; Goksen D; Darcan S; Tukun A; Ozkinay F
    Indian J Pediatr; 2016 Jun; 83(6):517-21. PubMed ID: 26817465
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [SOS1 mutation: a new cause of Noonan syndrome].
    Serrano-Martín MM; Martínez-Aedo MJ; Tartaglia M; López-Siguero JP
    An Pediatr (Barc); 2008 Apr; 68(4):365-8. PubMed ID: 18394382
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.